YA II PN, Ltd. 13D/13G Filings for TransCode Therapeutics, Inc. (RNAZ)

YA II PN, Ltd. 13D and 13G filings for TransCode Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-04-20
4:56 pm
Purchase
2026-04-1513GTRANSCODE THERAPEUTICS INC
RNAZ
YA II PN, Ltd.101,772
9.900%
101,772increase
(New Position)
Filing